Adherence to All Prescriptions After Heart Attack Improves Outcomes

Aimee Simone, Assistant Editor
Published Online: Thursday, January 30, 2014
Follow Pharmacy_Times:
Post-myocardial infarction patients who had each of their preventive medications on hand at least 80% of the time had significantly lower rates of major vascular events or revascularization than controls.

Patients who are highly adherent to all of their prescription medications are less likely to be readmitted to the hospital following a heart attack, according to a new study conducted by researchers from CVS Caremark and Brigham and Women’s Hospital. The results of the study indicate that patients who were adherent less than 80% of the time had no reduction in risk, suggesting that this widely used definition of adherence is a useful threshold.
Although many studies have demonstrated the benefits of medication adherence, there is little evidence regarding precisely what level of adherence is required and whether adherence to all prescriptions is necessary to improve outcomes. The new study, published in the January 2014 issue of the American Heart Journal, analyzed data from the MI FREEE trial to determine the impact of adherence on clinical outcomes for patients after myocardial infarction.
The analysis included trial patients who had filled a prescription for a beta-blocker, statin, angiotensin-converting enzyme inhibitor, or angiotensin receptor blocker after hospital discharge for myocardial infarction. Medication adherence was evaluated based on the portion of days covered for each medication prescribed, and patients were categorized based on their level of adherence. Patients who achieved a medication possession ratio of 80% or greater were categorized as adherent, those with a ratio from 60% to 79% were categorized as partially adherent, and those who were covered less than 60% of the time were categorized as non-adherent. Readmission rates for a first major vascular event, including myocardial infarction, unstable angina, stroke, and congestive heart failure, and coronary revascularization were assessed for all patients and compared across all 3 levels of adherence.
The results indicated that patients categorized as adherent to all medications included in the study were significantly less likely to experience major vascular events or undergo revascularization compared with control patients. Adherent patients had a 24% reduced hazard of experiencing a major vascular event or undergoing revascularization compared with controls, while non-adherent patients saw no reduction in risk. Surprisingly, there was no significant difference in the risk for vascular event between partially adherent patients and non-adherent patients. For example, patients who were partially adherent to beta-blockers had an average medication possession ratio of 71%, compared with just 49% among non-adherent patients, but risks of major vascular events or revascularization were equivalent among these patients.
The results indicate that adherence to all preventive medications by patients who have had a myocardial infarction is necessary in order to reduce the risk of re-admittance. The findings also provide support for defining optimal adherence as a medication possession ratio of 80% or greater, the study authors suggest, adding that interventions to improve adherence are needed.
“[I]nterventions that simplify treatment regimens, remind, and motivate patients about the importance of taking their therapies as prescribed may hold substantial promise and should be explored further,” they conclude.

Related Articles
Measles cases in Arizona and elsewhere could soar as football fans pour into the state for the Super Bowl.
A primary goal of managing atrial fibrillation is relief of symptoms that include dizziness, fatigue, palpitations, shortness of breath, and chest pain. Yet, it is symptomless in up to one-third of patients.
Women diagnosed with polycystic ovary syndrome are more likely to develop heart disease, diabetes, and other chronic conditions than those without the hormone disorder.
Pharmacist collaboration with physicians during a national shortage of intravenous trimethoprim/sulfamethoxazole may have helped mitigate negative treatment outcomes among HIV-infected patients with Pneumocystis jirovecii pneumonia.
Latest Issues
  • photo
    Pharmacy Times
    Health-System Edition
    Directions in Pharmacy
    OTC Guide
    Generic Supplements
  • photo
    Pharmacy Careers
    Specialty Pharmacy Times